Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
24
10
14
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
4.2%
1 terminated/withdrawn out of 24 trials
66.7%
-19.8% vs industry average
4%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
Role: collaborator
Lung Cancer Prevention Screening Programme in Italy
Role: collaborator
Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)
Role: collaborator
Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer
Role: collaborator
Clear Cell Chondrosarcoma in Italy
Role: collaborator
Effect of Prehabilitation on Head and Neck Cancer Patients
Role: collaborator
Driving Pressure During General Anesthesia for Open Abdominal Surgery
Role: collaborator
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
Role: collaborator
Adaptation of the PROFFIT Instrument Into Turkish: A Validity and Reliability Study
Role: collaborator
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Role: collaborator
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Role: collaborator
Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
Role: collaborator
tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr
Role: collaborator
Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life
Role: collaborator
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Role: collaborator
A Composite Assay for HER2-positive Early-stage Breast Cancer Management
Role: collaborator
Validation of the European Oncology Quality of Life Toolkit
Role: collaborator
New Preclinical and Clinical Approaches to Mesothelioma
Role: collaborator
Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy
Role: collaborator
PRO Survivorship Concerns ITA
Role: collaborator